Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Human Hepatitis B Immunoglobulin (IM) market report explains the definition, types, applications, major countries, and major players of the Human Hepatitis B Immunoglobulin (IM) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Shanghai RAAS
Hualan Biological
Grifols
Tiantan Biologic
China Biologic
CSL
Shuanglin Bio-pharmacy
Sichuan Yuanda Shuyang
Boya Bio-pharmaceutical
Octapharma
Shanghai Institute of Biological
Bayer
Baxter
By Type:
100IU/Bottle Human Hepatitis B Immunoglobulin (IM)
200IU/Bottle Human Hepatitis B Immunoglobulin (IM)
400IU/Bottle Human Hepatitis B Immunoglobulin (IM)
By End-User:
Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg)
Unexpected Crowd of Hepatitis B Infection
Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Human Hepatitis B Immunoglobulin (IM) Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Human Hepatitis B Immunoglobulin (IM) Outlook to 2028- Original Forecasts
-
2.2 Human Hepatitis B Immunoglobulin (IM) Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Human Hepatitis B Immunoglobulin (IM) Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Human Hepatitis B Immunoglobulin (IM) Market- Recent Developments
-
6.1 Human Hepatitis B Immunoglobulin (IM) Market News and Developments
-
6.2 Human Hepatitis B Immunoglobulin (IM) Market Deals Landscape
7 Human Hepatitis B Immunoglobulin (IM) Raw Materials and Cost Structure Analysis
-
7.1 Human Hepatitis B Immunoglobulin (IM) Key Raw Materials
-
7.2 Human Hepatitis B Immunoglobulin (IM) Price Trend of Key Raw Materials
-
7.3 Human Hepatitis B Immunoglobulin (IM) Key Suppliers of Raw Materials
-
7.4 Human Hepatitis B Immunoglobulin (IM) Market Concentration Rate of Raw Materials
-
7.5 Human Hepatitis B Immunoglobulin (IM) Cost Structure Analysis
-
7.5.1 Human Hepatitis B Immunoglobulin (IM) Raw Materials Analysis
-
7.5.2 Human Hepatitis B Immunoglobulin (IM) Labor Cost Analysis
-
7.5.3 Human Hepatitis B Immunoglobulin (IM) Manufacturing Expenses Analysis
8 Global Human Hepatitis B Immunoglobulin (IM) Import and Export Analysis (Top 10 Countries)
-
8.1 Global Human Hepatitis B Immunoglobulin (IM) Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Human Hepatitis B Immunoglobulin (IM) Export by Region (Top 10 Countries) (2017-2028)
9 Global Human Hepatitis B Immunoglobulin (IM) Market Outlook by Types and Applications to 2022
-
9.1 Global Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 100IU/Bottle Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 200IU/Bottle Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 400IU/Bottle Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Unexpected Crowd of Hepatitis B Infection Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Human Hepatitis B Immunoglobulin (IM) Market Analysis and Outlook till 2022
-
10.1 Global Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.2.2 Canada Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.2.3 Mexico Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.3.2 UK Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.3.3 Spain Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.3.4 Belgium Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.3.5 France Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.3.6 Italy Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.3.7 Denmark Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.3.8 Finland Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.3.9 Norway Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.3.10 Sweden Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.3.11 Poland Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.3.12 Russia Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.3.13 Turkey Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.4.2 Japan Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.4.3 India Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.4.4 South Korea Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.4.5 Pakistan Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.4.6 Bangladesh Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.4.7 Indonesia Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.4.8 Thailand Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.4.9 Singapore Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.4.10 Malaysia Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.4.11 Philippines Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.4.12 Vietnam Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.5.2 Colombia Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.5.3 Chile Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.5.4 Argentina Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.5.5 Venezuela Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.5.6 Peru Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.5.7 Puerto Rico Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.5.8 Ecuador Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.6.2 Kuwait Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.6.3 Oman Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.6.4 Qatar Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.6.5 Saudi Arabia Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.6.6 United Arab Emirates Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.7.2 South Africa Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.7.3 Egypt Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.7.4 Algeria Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
-
10.8.2 New Zealand Human Hepatitis B Immunoglobulin (IM) Consumption (2017-2022)
11 Global Human Hepatitis B Immunoglobulin (IM) Competitive Analysis
-
11.1 Shanghai RAAS
-
11.1.1 Shanghai RAAS Company Details
-
11.1.2 Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
11.1.4 Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Hualan Biological
-
11.2.1 Hualan Biological Company Details
-
11.2.2 Hualan Biological Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Hualan Biological Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
11.2.4 Hualan Biological Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Grifols
-
11.3.1 Grifols Company Details
-
11.3.2 Grifols Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Grifols Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
11.3.4 Grifols Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Tiantan Biologic
-
11.4.1 Tiantan Biologic Company Details
-
11.4.2 Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
11.4.4 Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 China Biologic
-
11.5.1 China Biologic Company Details
-
11.5.2 China Biologic Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 China Biologic Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
11.5.4 China Biologic Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 CSL
-
11.6.1 CSL Company Details
-
11.6.2 CSL Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 CSL Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
11.6.4 CSL Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Shuanglin Bio-pharmacy
-
11.7.1 Shuanglin Bio-pharmacy Company Details
-
11.7.2 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
11.7.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Sichuan Yuanda Shuyang
-
11.8.1 Sichuan Yuanda Shuyang Company Details
-
11.8.2 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
11.8.4 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Boya Bio-pharmaceutical
-
11.9.1 Boya Bio-pharmaceutical Company Details
-
11.9.2 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
11.9.4 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Octapharma
-
11.10.1 Octapharma Company Details
-
11.10.2 Octapharma Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Octapharma Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
11.10.4 Octapharma Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Shanghai Institute of Biological
-
11.11.1 Shanghai Institute of Biological Company Details
-
11.11.2 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
11.11.4 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Bayer
-
11.12.1 Bayer Company Details
-
11.12.2 Bayer Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Bayer Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
11.12.4 Bayer Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Baxter
-
11.13.1 Baxter Company Details
-
11.13.2 Baxter Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Baxter Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
11.13.4 Baxter Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global Human Hepatitis B Immunoglobulin (IM) Market Outlook by Types and Applications to 2028
-
12.1 Global Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global 100IU/Bottle Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global 200IU/Bottle Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global 400IU/Bottle Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Unexpected Crowd of Hepatitis B Infection Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Human Hepatitis B Immunoglobulin (IM) Market Analysis and Outlook to 2028
-
13.1 Global Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.2.2 Canada Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.2.3 Mexico Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.3.2 UK Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.3.3 Spain Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.3.4 Belgium Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.3.5 France Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.3.6 Italy Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.3.7 Denmark Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.3.8 Finland Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.3.9 Norway Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.3.10 Sweden Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.3.11 Poland Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.3.12 Russia Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.3.13 Turkey Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.4.2 Japan Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.4.3 India Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.4.4 South Korea Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.4.8 Thailand Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.4.9 Singapore Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.4.11 Philippines Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.5.2 Colombia Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.5.3 Chile Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.5.4 Argentina Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.5.6 Peru Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.6.3 Oman Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.6.4 Qatar Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.7.2 South Africa Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.7.3 Egypt Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.7.4 Algeria Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Human Hepatitis B Immunoglobulin (IM) Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Human Hepatitis B Immunoglobulin (IM)
-
Figure of Human Hepatitis B Immunoglobulin (IM) Picture
-
Table Global Human Hepatitis B Immunoglobulin (IM) Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Human Hepatitis B Immunoglobulin (IM) Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global 100IU/Bottle Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Global 200IU/Bottle Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Global 400IU/Bottle Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Global Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg) Consumption and Growth Rate (2017-2022)
-
Figure Global Unexpected Crowd of Hepatitis B Infection Consumption and Growth Rate (2017-2022)
-
Figure Global Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers Consumption and Growth Rate (2017-2022)
-
Figure Global Human Hepatitis B Immunoglobulin (IM) Consumption by Country (2017-2022)
-
Table North America Human Hepatitis B Immunoglobulin (IM) Consumption by Country (2017-2022)
-
Figure United States Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Canada Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Mexico Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Table Europe Human Hepatitis B Immunoglobulin (IM) Consumption by Country (2017-2022)
-
Figure Germany Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure UK Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Spain Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Belgium Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure France Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Italy Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Denmark Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Finland Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Norway Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Sweden Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Poland Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Russia Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Turkey Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Table APAC Human Hepatitis B Immunoglobulin (IM) Consumption by Country (2017-2022)
-
Figure China Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure India Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Thailand Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Singapore Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Philippines Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Table South America Human Hepatitis B Immunoglobulin (IM) Consumption by Country (2017-2022)
-
Figure Brazil Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Colombia Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Chile Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Argentina Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Peru Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Table GCC Human Hepatitis B Immunoglobulin (IM) Consumption by Country (2017-2022)
-
Figure Bahrain Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Oman Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Qatar Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Table Africa Human Hepatitis B Immunoglobulin (IM) Consumption by Country (2017-2022)
-
Figure Nigeria Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure South Africa Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Egypt Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure Algeria Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Table Oceania Human Hepatitis B Immunoglobulin (IM) Consumption by Country (2017-2022)
-
Figure Australia Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Human Hepatitis B Immunoglobulin (IM) Consumption and Growth Rate (2017-2022)
-
Table Shanghai RAAS Company Details
-
Table Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
Table Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
Table Hualan Biological Company Details
-
Table Hualan Biological Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hualan Biological Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
Table Hualan Biological Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
Table Grifols Company Details
-
Table Grifols Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
Table Grifols Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
Table Tiantan Biologic Company Details
-
Table Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
Table Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
Table China Biologic Company Details
-
Table China Biologic Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
Table China Biologic Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
Table China Biologic Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
Table CSL Company Details
-
Table CSL Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
Table CSL Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
Table Shuanglin Bio-pharmacy Company Details
-
Table Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
Table Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
Table Sichuan Yuanda Shuyang Company Details
-
Table Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
Table Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
Table Boya Bio-pharmaceutical Company Details
-
Table Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
Table Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
Table Octapharma Company Details
-
Table Octapharma Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Octapharma Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
Table Octapharma Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
Table Shanghai Institute of Biological Company Details
-
Table Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
Table Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
Table Bayer Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
Table Baxter Company Details
-
Table Baxter Human Hepatitis B Immunoglobulin (IM) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Human Hepatitis B Immunoglobulin (IM) Main Business and Markets Served
-
Table Baxter Human Hepatitis B Immunoglobulin (IM) Product Portfolio
-
Figure Global 100IU/Bottle Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 200IU/Bottle Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 400IU/Bottle Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Unexpected Crowd of Hepatitis B Infection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Human Hepatitis B Immunoglobulin (IM) Consumption Forecast by Country (2022-2028)
-
Table North America Human Hepatitis B Immunoglobulin (IM) Consumption Forecast by Country (2022-2028)
-
Figure United States Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Hepatitis B Immunoglobulin (IM) Consumption Forecast by Country (2022-2028)
-
Figure Germany Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Human Hepatitis B Immunoglobulin (IM) Consumption Forecast by Country (2022-2028)
-
Figure China Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Human Hepatitis B Immunoglobulin (IM) Consumption Forecast by Country (2022-2028)
-
Figure Brazil Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Human Hepatitis B Immunoglobulin (IM) Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Human Hepatitis B Immunoglobulin (IM) Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Human Hepatitis B Immunoglobulin (IM) Consumption Forecast by Country (2022-2028)
-
Figure Australia Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Human Hepatitis B Immunoglobulin (IM) Consumption Forecast and Growth Rate (2022-2028)
-
